EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TLR-mediated calcium signaling regulates killing capacity of expanded NK cells: challenges for potential AML immunotherapy

Vojtěch Graman, Adéla Jílková, Marek Jedlička, Veronika Švubová, Zuzana Tomášiková, Matúš Otruba, Kateřina Kuglerová, Eva Mašínová iD, Jana Szabová, Michal Santocki iD, Tereza Fiedlerová, Marcela Hortová Kohoutková und 1 weitere

Journal of Leukocyte Biology · 03.07.2026 · 118 (7)

DOI: 10.1093/jleuko/qiag092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 24.07.2026. Verfasst von Vojtěch Graman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Modern Immunotherapy Research, Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2 128 00, Czechia. Hauptthemen laut MEDLINE: Killer Cells, Natural, Calcium Signaling, Toll-Like Receptors, Leukemia, Myeloid, Acute. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health of the Czech Republic, DRO, Institute of Hematology and Blood Transfusion).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are central to cancer immunosurveillance and immunotherapy. Their ability to engage in killing is critical for efficient target elimination and depends on tightly regulated Ca2+ signaling controlling granzyme degranulation. Toll-like receptor (TLR) engagement has been linked to Ca2+ signaling in other immune cell types, while a specific role in NK cells remains unresolved. Given that NK cells express a broad range of TLRs, and that presence of TLR ligands—including damage- and pathogen-associated molecular patterns—can influence clinical scenarios including adoptive NK cell therapy, investigating TLR-driven Ca2+ signaling in NK cells is particularly relevant. Here, we examined how stimulation with selected TLR ligands influences Ca2+ signaling and NK cell activity. Immediate stimulation induced a rapid elevation of cytosolic Ca2+ in expanded NK cells. Functionally, TLR stimulation increased degranulation and enhanced cytotoxicity at high effector-to-target ratios. Under conditions of target excess, however, TLR-treated NK cells displayed impaired killing, likely due to unbalanced Ca2+ levels. These findings demonstrate that TLR signaling directly modulates Ca2+ flux in NK cells and can either potentiate or impair cytotoxic activity depending on context. Although clinical implications remain hypothetical, such TLR-driven dysregulation affects NK cell killing activity in the inflammatory or pathogen-rich environments frequently encountered after chemotherapy. Our findings suggest that TLR–Ca2+ impact on cytotoxicity should be considered in adoptive transfer therapies where previous treatment affects systemic levels of TLR ligands, such as in patients with acute myeloid leukemia, where NK cell immunotherapy is frequently tested in trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalCalcium SignalingToll-Like ReceptorsLeukemia, Myeloid, AcuteImmunotherapyCytotoxicity, ImmunologicHumansToll-Like Receptor AgonistsCalciumCell Degranulation

Stichwörter der Autor:innen

AMLNK cellcalciumcytotoxicitytoll-like receptor

Substanzen

Toll-Like ReceptorsToll-Like Receptor AgonistsCalcium

Autor:innen und Institutionen

  • Department of Modern Immunotherapy Research, Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2 128 00, Czechia.
  • Department of Cell Biology, Faculty of Science, Charles University, Albertov 6, Prague 2 128 00, Czechia.
  • Cellular and Molecular Immunoregulation, International Clinical Research Center, St.Anne's University Hospital Brno, Pekařská 53, Brno 656 91, Czechia.
  • Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, Brno 625 00, Czechia.
  • International Clinical Research Center, Faculty of Medicine, Masaryk University, Kamenice 753/5, Brno 625 00, Czechia.

ORCID-Profile: Eva Mašínová, Michal Santocki, Jan Frič

Förderung

  • Ministry of Health of the Czech Republic
  • DRO
  • Institute of Hematology and Blood Transfusion)
  • European Regional Development Fund
  • Finnish Red Cross Blood Service Research Fund
  • European Union project EATRIS-CZ
  • COST Action
  • EU-Resolution Biology Network

Zitieren

APA

Graman, V., Jílková, A., Jedlička, M., Švubová, V., Tomášiková, Z., Otruba, M., Kuglerová, K., Mašínová, E., Szabová, J., Santocki, M., Fiedlerová, T., Kohoutková, M. H., & Frič, J. (2026). TLR-mediated calcium signaling regulates killing capacity of expanded NK cells: challenges for potential AML immunotherapy. Journal of Leukocyte Biology, 118(7). https://doi.org/10.1093/jleuko/qiag092

Vancouver

Graman V, Jílková A, Jedlička M, Švubová V, Tomášiková Z, Otruba M, et al. TLR-mediated calcium signaling regulates killing capacity of expanded NK cells: challenges for potential AML immunotherapy. Journal of Leukocyte Biology. 2026;118(7). doi:10.1093/jleuko/qiag092

BibTeX
@article{Graman2026,
  author = {Graman, Vojtěch and Jílková, Adéla and Jedlička, Marek and Švubová, Veronika and Tomášiková, Zuzana and Otruba, Matúš and Kuglerová, Kateřina and Mašínová, Eva and Szabová, Jana and Santocki, Michal and Fiedlerová, Tereza and Kohoutková, Marcela Hortová and Frič, Jan},
  title = {TLR-mediated calcium signaling regulates killing capacity of expanded NK cells: challenges for potential AML immunotherapy},
  journal = {Journal of Leukocyte Biology},
  year = {2026},
  volume = {118},
  number = {7},
  doi = {10.1093/jleuko/qiag092}
}
Kostenlos starten →